Uncategorised - European Medical Journal

Alcaligenes faecalis Accelerates Diabetic Wound Healing

Research suggests that Alcaligenes faecalis, a bacterium found in many chronic wounds, can aid in healing difficult-to-treat wounds, especially in people with diabetes.

Common Antibiotics Linked to Risk of Life-Threatening Reactions

New study shows sulfonamides and cephalosporins carry the highest risk for serious cutaneous adverse drug reactions among antibiotics, particularly in older adults.

Barrett’s Oesophagus After Sleeve Gastrectomy: Is There a Risk?

Recent research highlights a significant increase in the risk of Barrett’s esophagus following sleeve gastrectomy, a commonly performed bariatric surgery

Liberal Transfusion Shows Comparable Outcomes in Brain Injury Recovery

A recent study finds that a liberal transfusion strategy does not improve neurological outcomes in critically ill patients with traumatic brain injury compared to a restrictive approach.

Intestinal Ultrasound Predicts Treatment Success in Paediatric Ulcerative Colitis

A study highlights the potential of intestinal ultrasound as a valuable tool for predicting treatment outcomes in children with moderate-to-severe ulcerative colitis.

Acute Myeloid Leukaemia Treatment Assessed for Patients Over 80

A multicentre study reveals the efficacy of Venetoclax with hypomethylating agents in treating acute myeloid leukemia in patients aged 80 and older.

Vutrisiran Reduces Mortality in Patients with Transthyretin Amyloidosis: ESC 2024

Presented at ESC 2024, vutrisiran, an RNAi therapeutic, significantly reduced mortality and cardiovascular events in patients with ATTR-CM.

Handshake on blue background

Novartis and Lindy Biosciences enter drug delivery partnership

The deal centres on Lindy’s microglassification technology, which facilitates high-concentration subcutaneous injections of biologic drugs.

Obesity Associated with Longer Survival in Immunotherapy-Treated Head, Neck Cancer

Obesity is linked to improved survival outcomes in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors.

Researchers

UK government unveils £400m plan to boost life science sector

The UK Government has launched a £400m public-private investment initiative, aiming to advance the pharmaceutical and life sciences sectors.